Bleeding manifestations in males with von Willebrand disease

Haemophilia

Volumn 10, Issue 2, 2004, Pages 162-168

  Ziv, O ^a   Ragni, Margaret V ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Males with bleeding disorders; Postoperative bleeding; Preoperative screening; von Willebrand disease

Indexed keywords

BLOOD CLOTTING FACTOR 8; DESMOPRESSIN; RISTOCETIN;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; BLEEDING TIME; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EPISTAXIS; FAMILY HISTORY; HEMARTHROSIS; HEPATITIS C; HUMAN; MALE; OSTEOARTHRITIS; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; SUBDURAL HEMATOMA; SYMPTOMATOLOGY; TONSILLECTOMY; UNITED STATES; VON WILLEBRAND DISEASE;

EID: 1542360814     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2003.00871.x     Document Type: Article

References (37)

1. Sadler JE, Mannucci PM, Berntorp E et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost 2000; 84: 160-74.
2. Miller CH, Lenzi R, Breen C. Prevalence of von Willebrand's disease among US adults. Blood 1987; 70 (Suppl. 1): 377a.
3. Werner EJ, Broxson EH, Tucker EL, Giroux DS, Shults J, Abshire TC. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr 1993; 123: 893-8.
4. Nichols WC, Ginsburg D. von Willebrand disease. Medicine 1997; 76: 1-20.
5. Ginsburg D, Handin RI, Bonthron DT et al. Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization. Science 1985; 228: 1401-6.
6. Eikenboom JCJ, Reitsma PH, Peerlinck KMJ, Briet E. Recessive inheritance of von Willebrand's disease type 1. Lancet 1993; 341: 982-6.
7. Meyer D, Fressinaud E, Gaucher C et al. Gene defects in 150 unrelated French cases with type 2 von Willebrand disease: from the patient to the gene. Thromb Haemost 1997; 78: 451-6.
8. Sadler JE. A revised classification of von Willebrand disease. Thromb Haemost 1994; 71: 520-5.
9. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691-5.
10. Rickles FR, Hoyer LW, Rick ME, Ahr DJ. The effects of epinephrine infusion in patients with von Willebrand disease. J Clin Invest 1976; 57: 1618-25.
11. Mandalaki T, Louizou C, Dmitriadou C, Symeonides PH. Variations in factor VIII during the menstrual cycle in normal women (Letter). N Engl J Med 1980; 302: 1093-4.
12. Liu L, Wang X, Lin Z, Wu H. Elevated plasma levels of vWF:Ag in hyperthyroidism are mediated through adrenergic receptors. Endocr Res 1993; 19: 123-33.
13. Bloom AL. The biosynthesis of factor VIII. Clin Haemotol 1979; 8: 53-77.
14. Ragni MV, Bontempo FA, Hassett AC. von Willebrand disease and bleeding in women. Haemophilia 1999; 5: 313-7.
15. Simone JV, Vanderheiden J, Abildgaard CF. A semi-automatic one-stage factor 8 assay with a commercially prepared standard. J Lab Clin Med 1967; 69: 706-12.
16. Rizza CR, Rhymes IL. Coagulation assay of VIII and IXC. In: Bloom KAL, ed. The Hemophilias. New York: Churchill Livingstone, 1982: 28-38.
17. Lamme S, Wallmark A, Holmberg L. The use of monoclonal antibodies in measuring factor VIII/von Willebrand factor. Scand J Lab Invest 1985; 15: 17-26.
18. Allain JP, Cooper HA, Wanger RH, Brinkhous KM. Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor. J Lab Clin Med 1975; 85: 318-28.
19. Kumar R, Ansell JE, Canoso RT, Deykin D. Clinical trials of a new bleeding time device. Am J Clin Path 1978; 70: 642-5.
20. Mammen EF, Comp PC, Gosselin R et al. PFA-100 system: a new method for assessment of platelet dysfunction. Semin Thromb Hemost 1996; 24: 195-202.
21. Raines G, Aumann H, Sykes S, Street A. Multimeric analysis of von Willebrand factor by molecular sieving electrophoresis in sodium dodecyl sulphate agarose gel. Thromb Res 1990; 60: 201-12.
22. Sadler JE. von Willebrand disease type 1: a diagnosis in search of a disease. Blood 2003; 101: 2089-93.
23. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987; 69: 454-9.
24. Castaman G, Eikenboom JCJ, Bertini RM, Rodeghiero F. Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation. Thromb Haemost 1999; 82: 105-70.
25. Werner EJ. von Willebrand disease in children and adolescents. Pediatr Hematol 1996; 43: 683-707.
26. Miller CH, Graham JB, Goldin LR. Genetics of classic von Willebrand disease. I. Phenotypic variation within families. Blood 1979; 54: 117-36.
27. Silwer J. von Willebrand's disease in Sweden. Acta Paediatr Scand 1973; 238 (Suppl.): 1-159.
28. Ranjit S, Brett RH, Lu PK, Aw CY. The incidence and management of post-tonsillectomy haemorrhage: a Singaporean experience. Singapore Med J 1999; 40: 622-6.
29. Faulconbride RVL, Fowler S, Horricks J, Topham JH. Comparative audit of tonsillectomy. Clin Otolaryngol Allied Sci 2000; 25: 110-17.
30. Federici AB, Sacco R, Stabile F, Carpenedo M, Zingaro E, Mannucci PM. Optimizing local therapy during oral surgery in patients with von Willebrand disease: effective results from a retrospective analysis of 63 cases. Haemophilia 2000; 6: 71-7.
31. Paradise JL. Tonsillectomy and adenoidectomy. In: Bluestone CD, Stool SE, Kenna MA, eds. Pediatric Otolaryngology, 3rd edn. Philadelphia, PA: W.B. Saunders, 1996: 1054-1065.
32. Werner EJ, Abshire TC, Giroux DS. Relative value of diagnostic studies in von Willebrand disease. J Pediatr 1992; 121: 34-8.
33. Burk CD, Miller R, Handler SD, Cohen AR. Preoperative history and coagulation screening in children undergoing tonsillectomy. Pediatrics 1992; 89: 691-5.
34. Biron C, Mahieu B, Rochette A et al. Preoperative screening for von Willebrand disease type 1: low yield and limited ability to predict bleeding. J Lab Clin Med 1999; 134: 605-9.
35. Schlammadinger A, Kerenyl A, Muszbek L, Boda Z. Comparison of the O'Brian Filter Test and the PFA-100 Platelet Analyzer in the laboratory diagnosis of von Willebrand disease. Thromb Haemost 2000; 84: 88-92.
36. Fressinaud E, Veyradier A, Siaud M, Boyer-Neumann C, Le Boterff C, Meyer D. Therapeutic monitoring of von Willebrand disease: interest and limits of a platelet function analyzer at high shear rates. Br J Haemotol 1999; 106: 777-83.
37. Dean JA, Blanchette VS, Carcao MD et al. von Willebrand disease in a pediatric-based population-comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay. Thromb Haemost 2000; 84: 401-9.